CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENTChange of Control and Severance Benefits Agreement • March 31st, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
This CHANGE OF CONTROL AND SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 4th day of March, 2009 (the “Effective Date”), between TRANSCEPT PHARMACEUTICALS, INC. (the “Company”) and Joseph T. Kennedy (“Executive”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events.
LEASE BETWEEN POINT RICHMOND R&D ASSOCIATES II, LLC, a California limited liability company (LANDLORD) AND TRANSCEPT PHARMACEUTICALS, INC., a Delaware corporation (TENANT) POINT RICHMOND II Point Richmond, CaliforniaLease • March 31st, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
SECOND AMENDMENT TO LEASELease • March 31st, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS SECOND AMENDMENT TO LEASE (the “Second Amendment”) is made and entered into as of February 9, 2009, by and between POINT RICHMOND R&D ASSOCIATES, a California limited partnership (“Landlord”), and TRANSCEPT PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”) with reference to the following facts:
